FDA-Approved Drugs Efavirenz, Tipranavir, and Dasabuvir Inhibit Replication of Multiple Flaviviruses in Vero Cells

Vector-borne flaviviruses (VBFs) affect human health worldwide, but no approved drugs are available specifically to treat VBF-associated infections. Here, we performed in silico screening of a library of U.S. Food and Drug Administration-approved antiviral drugs for their interaction with Zika virus...

Descripción completa

Detalles Bibliográficos
Autores principales: Stefanik, Michal, Valdes, James J., Ezebuo, Fortunatus C., Haviernik, Jan, Uzochukwu, Ikemefuna C., Fojtikova, Martina, Salat, Jiri, Eyer, Ludek, Ruzek, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232190/
https://www.ncbi.nlm.nih.gov/pubmed/32326119
http://dx.doi.org/10.3390/microorganisms8040599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232190/
https://www.ncbi.nlm.nih.gov/pubmed/32326119
http://dx.doi.org/10.3390/microorganisms8040599

Ejemplares similares